Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial-Reference-Cited by-同舟云学术

Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial

Published:2017-03 Issue:3 Volume:2 Page:177-188
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Bourlière Marc,Rabiega Pascaline,Ganne-Carrie Nathalie,Serfaty Lawrence,Marcellin Patrick,Barthe Yoann,Thabut Dominique,Guyader Dominique,Hezode Christophe,Picon Magali,Causse Xavier,Leroy Vincent,Bronowicki Jean Pierre,Carrieri Patrizia,Riachi Ghassan,Rosa Isabelle,Attali Pierre,Molina Jean Michel,Bacq Yannick,Tran Albert,Grangé Jean Didier,Zoulim Fabien,Fontaine Hélène,Alric Laurent,Bertucci Inga,Bouvier-Alias Magali,Carrat Fabrice

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. Chronic hepatitis B: update 2009;Lok;Hepatology,2009

2. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2015 update;Martin;Clin Gastroenterol Hepatol,2015

3. EASL clinical practice guidelines: management of chronic hepatitis B virus infection;J Hepatol,2012

4. HBV cure: why, how, when?;Levrero;Curr Opin Virol,2016

5. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B;Marcellin;N Engl J Med,2004

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review with network meta-analysis: sustained hepatitis B surface antigen clearance after pegylated interferon cessation;European Journal of Gastroenterology & Hepatology;2024-07-22

2. Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression;Pharmaceuticals;2024-07-21

3. Trajectories of Serum Hepatitis B Surface antigen (HBsAg) During Treatment and Association With HBsAg Loss in Children With Hepatitis B e Antigen–Positive Chronic Hepatitis B: A Latent Class Trajectory Analysis;The Journal of Infectious Diseases;2024-07-05

4. Hepatitis B cure: Current situation and prospects;World Journal of Hepatology;2024-06-27

5. Predictive models for functional cure in patients with CHB receiving PEG-IFN therapy based on HBsAg quantification through meta-analysis;Hepatology International;2024-06-24